Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-controlled Prospective Pilot Study Assessing Prognostic Performance of Circulating Tumour DNA Kinetic Analysis for Monitoring Response to Treatment of Metastatic Non-small Cell Lung Cancers

NCT03926260 is registered in ClinicalTrials.gov with Centre Hospitalier Departemental Vendee as lead sponsor.

NCT NCT03926260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03926260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-controlled Prospective Pilot Study Assessing Prognostic Performance of Circulating Tumour DNA Kinetic Analysis for Monitoring Response to Treatment of Metastatic Non-small Cell Lung Cancers
Lead sponsor
Centre Hospitalier Departemental Vendee
Phase
Not applicable
Overall status
Completed
Start date
June 27, 2019
Completion date
May 23, 2022
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic non-small cell lung cancer